Advanced Nanomaterials for Cancer Therapy: Gold, Silver, and Iron Oxide Nanoparticles in Oncological Applications
Reviewartikel, 2024

Cancer remains one of the most challenging health issues globally, demanding innovative therapeutic approaches for effective treatment. Nanoparticles, particularly those composed of gold, silver, and iron oxide, have emerged as promising candidates for changing cancer therapy. This comprehensive review demonstrates the landscape of nanoparticle-based oncological interventions, focusing on the remarkable advancements and therapeutic potentials of gold, silver, and iron oxide nanoparticles. Gold nanoparticles have garnered significant attention for their exceptional biocompatibility, tunable surface chemistry, and distinctive optical properties, rendering them ideal candidates for various cancer diagnostic and therapeutic strategies. Silver nanoparticles, renowned for their antimicrobial properties, exhibit remarkable potential in cancer therapy through multiple mechanisms, including apoptosis induction, angiogenesis inhibition, and drug delivery enhancement. With their magnetic properties and biocompatibility, iron oxide nanoparticles offer unique cancer diagnosis and targeted therapy opportunities. This review critically examines the recent advancements in the synthesis, functionalization, and biomedical applications of these nanoparticles in cancer therapy. Moreover, the challenges are discussed, including toxicity concerns, immunogenicity, and translational barriers, and ongoing efforts to overcome these hurdles are highlighted. Finally, insights into the future directions of nanoparticle-based cancer therapy and regulatory considerations, are provided aiming to accelerate the translation of these promising technologies from bench to bedside.

cancer therapy

gold nanoparticles

diagnostic

drug delivery

personalized medicine

combination therapy

silver nanoparticles

imaging, iron oxide nanoparticles

metallic nanoparticles

Författare

Priyanka Singh

Novo Nordisk Fonden

Santosh Pandit

Chalmers, Life sciences, Systembiologi

Sri Renukadevi Balusamy

Sejong University

Mukil Madhusudanan

Novo Nordisk Fonden

Hina Singh

UCR School of Medicine

H. Mohamed Amsath Haseef

Faculteit Ingenieurswetenschappen

Ivan Mijakovic

Novo Nordisk Fonden

Chalmers, Life sciences, Systembiologi

Advanced healthcare materials

2192-2640 (ISSN) 2192-2659 (eISSN)

Vol. In Press

Graphene-based drug delivery systems for treating MRSA infections

NordForsk (105121), 2021-01-01 -- 2023-12-31.

Ämneskategorier

Cancer och onkologi

DOI

10.1002/adhm.202403059

PubMed

39501968

Mer information

Senast uppdaterat

2024-11-22